Skip to Content

Cannabis Global Inc CBGL

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CBGL is trading at a 382% premium.
Price
$0.00
Fair Value
$5.39
Uncertainty
Extreme
1-Star Price
$1.91
5-Star Price
$3.71
Economic Moat
Bkkc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CBGL is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$209,031.05
Volume/Avg
16.2 Mil / 21.3 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Cannabis Global manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
3

Valuation

Metric
CBGL
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
CBGL

Financial Strength

Metric
CBGL
Quick Ratio
0.11
Current Ratio
0.21
Interest Coverage
0.27
Quick Ratio
CBGL

Profitability

Metric
CBGL
Return on Assets (Normalized)
−48.76%
Return on Equity (Normalized)
−674.40%
Return on Invested Capital (Normalized)
−13.37%
Return on Assets
CBGL
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
CxmtthmfqNxj$81.8 Bil
Merck KGaA ADR
MKKGY
ZvrhwqnzrWvltpsb$72.6 Bil
Haleon PLC ADR
HLN
ZcwkhcntJjvw$40.4 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
LhdxwspQzq$18.2 Bil
Viatris Inc
VTRS
TjwnbchWlbs$14.0 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
YvjmqmrQzpz$13.3 Bil
Catalent Inc
CTLT
WbpddmsbTjzmzz$10.5 Bil
Perrigo Co PLC
PRGO
BdmrqmhxdRsbbm$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
XxvbfrnnjCxzfkj$3.6 Bil
Curaleaf Holdings Inc
CURLF
PmbkxfnNlfb$3.2 Bil

Sponsor Center